Orange Quantum Systems: Capital Raising

The leadership read

Orange Quantum Systems has moved from building quantum chip testing instruments to scaling the infrastructure behind them, a materially different operating commitment. A seed extension at this size, in Delft, points to a bet that the bottleneck in quantum hardware development is not chip design but the verification layer: the tooling that tells a lab whether a chip actually works before it goes anywhere near a customer. By expanding that infrastructure, OrangeQS is positioning itself as a horizontal dependency across multiple quantum hardware programmes, which means its operational surface now includes supply chain for cryogenic and precision measurement components, capacity planning tied to third-party R&D timelines, and the quality and calibration standards that make its test data credible to hardware partners. The related signals here are genuinely thin for quantum hardware specifically, the 12 comparables are capital-raising events across deep tech, AI infrastructure, and health, with Keiron Printing Technologies (€20.7m Series A for precision materials-deposition) being the closest structural analogue as a tool-layer company serving a hardware development ecosystem. The broader pattern is capital continuing to flow into deep-tech infrastructure plays, not the end application, but the enabling layer, which is consistent with where European deep-tech investment has concentrated through early 2026. Companies reaching this stage of infrastructure buildout in quantum and adjacent precision hardware corridors face increasing demand for leadership in technical operations, metrology and standards, and commercial functions capable of managing long-cycle partnerships with national labs, hardware OEMs, and sovereign research programmes. The market is moving toward operators who can translate instrument performance into procurement language that research institutions and early quantum-computing customers can act on.